Sparse representation for classification of tumors using gene expression data.
Personalized drug design requires the classification of cancer patients as accurate as possible. With advances in genome sequencing and microarray technology, a large amount of gene expression data has been and will continuously be produced from various cancerous patients. Such cancer-alerted gene e...
| Publicado en: | Journal of Biomedicine & Biotechnology pp. 6p - 7 |
|---|---|
| Autores principales: | , |
| Formato: | equations & formulas research tables/charts Journal Article |
| Publicado: |
Wiley-Blackwell
2009 Regular Issue
|
| Acceso en línea: | Ver este registro en EBSCOhost |